by Charlene A Flash, Sannisha K Dale, Douglas S Krakower
International Journal of Women’s Health (May 2017), 9: 391–401

11 pp. 308 kB
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459979/pdf/ijwh-9-391.pdf

This narrative review summarizes the efficacy and safety data of PrEP in women, discusses considerations related to medication adherence for women who use PrEP, and highlights behavioral, social, and structural barriers to maximize the effectiveness of PrEP in women. It also reviews novel modalities for PrEP in women which are being developed and tested, including topical formulations and long-acting injectable agents that may offer advantages as compared to oral PrEP and proposes a community-oriented, social networking framework to increase awareness of PrEP among women. If women are provided with access to PrEP and support to overcome social and structural barriers to adhere to PrEP, this prevention strategy holds great promise to impact the HIV epidemic among women in the US and globally.

(Visited 7 times, 1 visits today)
This entry was posted in General, HIV - AIDS - STI, Maternal & Child Health. Bookmark the permalink.
Facebook Auto Publish Powered By : XYZScripts.com
Get the latest issue of the NewsletterDownload